{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:03:11Z","timestamp":1784332991038,"version":"3.55.0"},"reference-count":52,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>\n                    The current era is characterized by the pursuit of novel medications and drug repurposing through innovative mechanisms that modulate systems beyond the monoaminergic, focusing on novel synaptic signaling targets. Against this backdrop, it can be challenging to recall a time when psychopharmacology was in its infancy, and every discovery represented the cutting edge. Nathan S. Kline, a clinician and researcher, was a pivotal figure in introducing the first psychoactive substances into clinical practice. His seminal work on reserpine as a sedative and his evaluation of the antidepressant properties of iproniazid, a monoamine oxidase inhibitor (MAOI), positioned him at the scientific vanguard of pharmacological psychiatry. Kline made multiple substantial contributions to the medical-scientific literature, publishing foundational papers on the use of reserpine in neuropsychiatric hospitals, the application of\n                    <jats:italic toggle=\"yes\">Rauwolfia serpentina<\/jats:italic>\n                    for neuropsychiatric conditions, and comparative studies of iproniazid and other MAOIs, among numerous other manuscripts. Kline\u2019s enduring legacy extends beyond psychopharmacology, encompassing early efforts in health informatics to optimize psychiatric logistics and advocacy for the expansion of global mental health care networks, including in low- and middle-income countries.\n                  <\/jats:p>","DOI":"10.1177\/02698811261436582","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:16:57Z","timestamp":1775564217000},"page":"1018-1025","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Nathan S. Kline: From the first treatments of psychosis and depression, a 70-year legacy of a pioneer of psychopharmacology"],"prefix":"10.1177","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3808-1152","authenticated-orcid":false,"given":"Larissa","family":"Junkes","sequence":"first","affiliation":[{"name":"Institute of Psychiatry (IPUB), Federal University of Rio de Janeiro (UFRJ), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard I.","family":"Shader","sequence":"additional","affiliation":[{"name":"Center for the Study of Drug Development, School of Medicine, Tufts University, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2152-4669","authenticated-orcid":false,"given":"Antonio E.","family":"Nardi","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry (IPUB), Federal University of Rio de Janeiro (UFRJ), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"e_1_3_3_2_1","volume-title":"Psychopharmacology: A Symposium Organized by the Section on Medical Sciences of the AAAS and the American Psychiatric Association and Presented at the Berkeley Meeting, December 30, 1954","author":"American Association for the Advancement of Science (AAAS)","year":"1956","unstructured":"American Association for the Advancement of Science (AAAS) (1956) Psychopharmacology: A Symposium Organized by the Section on Medical Sciences of the AAAS and the American Psychiatric Association and Presented at the Berkeley Meeting, December 30, 1954 (eds Kline NS and American Association for the Advancement of Science). American Association for the Advancement of Science."},{"key":"e_1_3_3_3_1","unstructured":"Ban TA Blackwell B Gershon S et al. (2013) International Network for the History of Neuropsychopharmacology Educational E-Books. Available at: https:\/\/inhn.org\/ (accessed 21 July 2025)."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.111.10.780"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurpsyc.1955.02330130033005"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1955.02960020016005"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurpsyc.1956.02330250092014"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.112.9.684"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.113.8.744"},{"key":"e_1_3_3_10_1","unstructured":"Blackwell B (2013) Pioneers and controversies in psychopharmacology. Available at: https:\/\/inhn.org\/fileadmin\/user_upload\/User_Uploads\/INHN\/EBOOKS\/Chapter_16_-_Enoch_Calloway_Parts_3-4_Blackwell_Pioneers.pdf (accessed 21 July 2025)."},{"issue":"9","key":"e_1_3_3_11_1","first-page":"26","article-title":"Cyborgs and space","volume":"14","author":"Clynes ME","year":"1960","unstructured":"Clynes ME, Kline NS (1960) Cyborgs and space. Astronautics 14(9): 26\u201327.","journal-title":"Astronautics"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0957154X07070335"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-8741(83)90029-6"},{"key":"e_1_3_3_14_1","volume-title":"The Serpent and the Rainbow: A Harvard Scientist\u2019s Astonishing Journey into the Secret Societies of Haitian Voodoo, Zombis and Magic","author":"Davis W","year":"1985","unstructured":"Davis W (1985) The Serpent and the Rainbow: A Harvard Scientist\u2019s Astonishing Journey into the Secret Societies of Haitian Voodoo, Zombis and Magic. Simon & Schuster."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.08.021"},{"key":"e_1_3_3_16_1","volume-title":"The Making of DSM-III\u00ae: A Diagnostic Manual\u2019s Conquest of American Psychiatry","author":"Decker HS","year":"2013","unstructured":"Decker HS (2013) The Making of DSM-III\u00ae: A Diagnostic Manual\u2019s Conquest of American Psychiatry. Oxford University Press."},{"issue":"2","key":"e_1_3_3_17_1","first-page":"112","article-title":"Utilisation en th\u00e9rapeutique psychiatrique d\u2019une ph\u00e9nothiazine d\u2019action centrale \u00e9lective (4560 RP)","volume":"110","author":"Delay J","year":"1952","unstructured":"Delay J, Deniker P, Harl JM (1952) Utilisation en th\u00e9rapeutique psychiatrique d\u2019une ph\u00e9nothiazine d\u2019action centrale \u00e9lective (4560 RP). Annales M\u00e9dico-Psychologiques 110(2): 112\u2013117.","journal-title":"Annales M\u00e9dico-Psychologiques"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001788"},{"key":"e_1_3_3_19_1","unstructured":"Ginalis E (2014) Nathan S. Kline\u2019s Zombi in Haiti. (Final Project Global Health 323). Duke University."},{"key":"e_1_3_3_20_1","article-title":"Nathan Kline, developer of antidepressants, dies","author":"Gruson K","year":"1983","unstructured":"Gruson K (1983, February 14) Nathan Kline, developer of antidepressants, dies. The New York Times, p. D10.","journal-title":"The New York Times"},{"key":"e_1_3_3_21_1","volume-title":"The Psychopharmacologists: Interviews by David Healey","author":"Healey D","year":"1998","unstructured":"Healey D (1998) The Psychopharmacologists: Interviews by David Healey. CRC Press."},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1017\/S146114579800114X"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.4159\/9780674038455"},{"key":"e_1_3_3_24_1","article-title":"Tranylcypromine: A red flag for broader reflection","volume":"46","author":"Junkes L","year":"2024","unstructured":"Junkes L, Nardi AE (2024) Tranylcypromine: A red flag for broader reflection. Brazilian Journal of Psychiatry 46: e20233491.","journal-title":"Brazilian Journal of Psychiatry"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107876"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1954.tb45922.x"},{"key":"e_1_3_3_27_1","volume-title":"Psychopharmacology","author":"Kline NS","year":"1956","unstructured":"Kline NS (ed.) (1956) Psychopharmacology. American Association for the Advancement of Science."},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01568706"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurpsyc.1957.02330360069007"},{"key":"e_1_3_3_30_1","first-page":"72","article-title":"Clinical experience with iproniazid (marsilid)","volume":"19","author":"Kline NS","year":"1958","unstructured":"Kline NS (1958) Clinical experience with iproniazid (marsilid). Journal of Clinical and Experimental Psychopathology 19(2, Suppl. 1): 72\u201378.","journal-title":"Journal of Clinical and Experimental Psychopathology"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)33861-5"},{"issue":"190","key":"e_1_3_3_32_1","first-page":"732","article-title":"The practical management of depression","volume":"23","author":"Kline NS","year":"1964","unstructured":"Kline NS (1964) The practical management of depression. JAMA 23(190): 732\u2013740.","journal-title":"JAMA"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.125.4.558"},{"key":"e_1_3_3_34_1","first-page":"194","volume-title":"Discoveries in Biological Psychiatry","author":"Kline NS","year":"1970","unstructured":"Kline NS (1970) Monoamine oxidase inhibitors: An unfinished picaresque tale. In: Ayd FJ, Blackwell B (eds) Discoveries in Biological Psychiatry. Lippincott, pp.194\u2013204."},{"key":"e_1_3_3_35_1","volume-title":"From Sad to Glad: Kline on Depression","author":"Kline NS","year":"1974","unstructured":"Kline NS (1974) From Sad to Glad: Kline on Depression. G. P. Putnam\u2019s Sons."},{"issue":"3","key":"e_1_3_3_36_1","first-page":"12","article-title":"Clinical observations with beta-endorphin injections","volume":"14","author":"Kline NS","year":"1978","unstructured":"Kline NS, Lehmann HE (1978) Clinical observations with beta-endorphin injections. Psychopharmacology Bulletin 14(3): 12\u201313.","journal-title":"Psychopharmacology Bulletin"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-440X(67)80036-1"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)34438-8"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1955.tb42454.x"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770210125012"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198212000-00035"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02174406"},{"key":"e_1_3_3_43_1","volume-title":"The Nathan S. Kline Institute for Psychiatric Research","author":"Nathan Kline Institute","unstructured":"Nathan Kline Institute (n.d.) The Nathan S. Kline Institute for Psychiatric Research. Nathan Kline Institute."},{"key":"e_1_3_3_44_1","volume-title":"Biographical Memoirs: Volume 66","author":"National Academy of Sciences","year":"1995","unstructured":"National Academy of Sciences (1995) Biographical Memoirs: Volume 66. The National Academies Press."},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31612-X"},{"key":"e_1_3_3_46_1","volume-title":"Tranquilizing Humanity into Oblivion: A Warning from Nathan S. Kline","author":"Ruffalo ML","year":"2017","unstructured":"Ruffalo ML (2017) Tranquilizing Humanity into Oblivion: A Warning from Nathan S. Kline. Mad in America\u2014Science, Psychiatry and Social Justice."},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.116.1.71"},{"issue":"5","key":"e_1_3_3_48_1","first-page":"418","article-title":"\u2018I am depressed\u2019: The many meanings that may underlie variability in response to antidepressants","volume":"45","author":"Shader RI","year":"2025","unstructured":"Shader RI, Nardi AE, Balon R, et al. (2025) \u2018I am depressed\u2019: The many meanings that may underlie variability in response to antidepressants. Journal of Clinical Psychopharmacology 45(5): 418\u2013420.","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"e_1_3_3_49_1","volume-title":"A Historical Dictionary of Psychiatry","author":"Shorter E","year":"2005","unstructured":"Shorter E (2005) A Historical Dictionary of Psychiatry. Oxford University Press."},{"key":"e_1_3_3_50_1","first-page":"116","article-title":"Difficulties in systematic rating of depression during out-patient drug treatment","volume":"11","author":"Simpson GM","year":"1966","unstructured":"Simpson GM, Hackett E, Kline NS (1966) Difficulties in systematic rating of depression during out-patient drug treatment. Canadian Journal of Psychiatry 11(Suppl.): 116\u2013122.","journal-title":"Canadian Journal of Psychiatry"},{"issue":"7","key":"e_1_3_3_51_1","first-page":"679","article-title":"Clozapine\u2014A new antipsychotic agent","volume":"16","author":"Simpson GM","year":"1974","unstructured":"Simpson GM, Varga E (1974) Clozapine\u2014A new antipsychotic agent. Current Therapeutic Research, Clinical and Experimental 16(7): 679\u2013686.","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"6","key":"e_1_3_3_52_1","article-title":"Nathan S. Kline: A remembrance","volume":"28","author":"Swartz CM","year":"2011","unstructured":"Swartz CM (2011) Nathan S. Kline: A remembrance. Psychiatric Times 28(6).","journal-title":"Psychiatric Times"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02174413"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811261436582","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811261436582","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811261436582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:19:01Z","timestamp":1784330341000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811261436582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1177\/02698811261436582"],"URL":"https:\/\/doi.org\/10.1177\/02698811261436582","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}